Osborne Clarke is advising TiGenix, an advanced biopharmaceutical company listed on Euronext Brussels and NASDAQ (TIG), in connection with the intended acquisition by Takeda Pharmaceutical Company…
Takeda’s acquisition of TiGenix, an advanced biopharmaceutical company
